Sirnaomics’ siRNA Therapeutic To Begin Clinical Trials In China

 
• By Dai Jialing

SHANGHAI - Sirnaomics' RNAi therapeutic STP601 will begin clinical trials in China in late 2008, Patrick Lu, founder, president and CEO of Sirnaomics, told PharmAsia News

More from Archive

More from Scrip